Intanza® 15 μg Intradermal Seasonal Influenza Vaccine in Older Adults (Aged ≥60 Years)Profile Report

被引:0
作者
Sean T. Duggan
Greg L. Plosker
机构
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源
BioDrugs | 2010年 / 24卷
关键词
Influenza; Rabies; Influenza Vaccine; Seroprotection Rate; Seasonal Influenza Vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:407 / 409
页数:2
相关论文
共 59 条
[1]  
Duggan S.T.(2010)Intanza® 15 mg intradermal seasonal influenza vaccine: in older adults (aged ≥60 years) Drugs Aging 27 597-605
[2]  
Plosker G.L.(2001)Influenza: vaccination and treatment Eur Respir J 17 1282-93
[3]  
Stephenson I.(2003)Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 179-86
[4]  
Nicholson K.G.(2008)Biology of immune responses to vaccines in elderly persons Clin Infect Dis 46 1078-84
[5]  
Thompson W.W.(2008)Antiviral treatment and prevention of seasonal influenza: a comparative review of recommendations in the European Union J Clin Virol 42 244-8
[6]  
Shay D.K.(2008)Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons BMC Public Health 8 272-69
[7]  
Weintraub E.(2009)Council recommendation of 22 December 2009 on seasonal influenza vaccination (text with EEA relevance) [2009/1019/EU] Official J European Union 348 71-46
[8]  
Weinberger B.(2006)Antibody response to influenza vaccination in the elderly: a quantitative review Vaccine 24 1159-14
[9]  
Herndler-Brandstetter D.(2007)Immunosenescence: emerging challenges for an ageing population Immunology 120 435-208
[10]  
Schwanninger A.(2008)Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice Expert Rev Vaccines 7 1201-301